Hep C drugs linked to hep B reactivation: study
The medications that cure nearly 90 per cent of hepatitis C patients but come with wallet-busting prices have another downside, a report by the Institute for Safe Medication Practices in the United States has found. In its quarterly report, it identified 1,582 cases in which direct-acting antiviral drugs for hepatitis C, such as Sovaldi and Harvoni, reactivated […]
- January 30, 2017 September 13, 2019
- 09:18